BRD-containing p300 NHEJ, HR Y 26,59,60]
HATs CBP NHEJ, HR Y 26,59,60]
SAGA, ATAC GCNS _ Y 27)
ATAC PCAF _ Y 27)
others p-TEFb BRD4 NHEJ â€” 61]
TRIM24 _ Y 27)
KAP1 (TRIM28) NHEJ, HR Y 62-64]
TRIM33 _ Y 27,65]
non-DDR-related ASHIL, ATAD2, ATAD2B, BAZ2A, BAZ2B, BRD1, BRD2, BRD3, BRDT, BRD9, BRPF1, BRPF3, BRWD1, BRWD3, CECR2, MLL, PHIP,

$P100, SP110, SP140, SP140L, TAF1, TAFIL, TRIM66, ZMYND11

mobilization and eviction of nucleosomes, which can modu- is underscored by the fact that acetylation modifiers and
late the local chromatin structure to allow DDR proteins to readers are frequently mutated or aberrantly expressed in
access the lesion to promote DNA repair activities within cancer [44,66-68]. Chromatin remodellers in general are
chromatin [41,42]. associated with DNA repair and transcription in cancer and
Acetylation signalling represents a key pathway for the ageing, topics that are specifically reviewed by Yasui and
detection, signalling and repair of DSBs. Acetylation is cata- co-workers in this issue [69]. Moreover, numerous studies
lysed by histone acetyltransferase (HAT) enzymes through have determined that these pathways represent attractive
the transfer of an acetyl group (-COCHs) to lysine residues targets for small molecule inhibitors either as single agents
within proteins including histones (figure 1). Acetyl groups or to sensitize cancer cells to chemo- or radiotherapy as a
from lysines are removed by histone deacetylase (HDAC) combination therapy [44,70]. For example, HDAC inhibitors
enzymes, allowing the dynamic regulation of this histone (HDACi) represent one of only a few epigenetic drugs that
mark (figure 1). The evidence for the importance of acety- are FDA approved as a treatment for certain cancers. Preclini-
lation in DNA damage signalling and repair of DSBs is cal studies have demonstrated the utility of these inhibitors in